Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04111471 · ClinicalTrials.gov registry record · NA
The Use of A Prebiotic to Promote a Healthy Gut Microbiome in Pediatric Stem Cell Transplant Recipients
A NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04111471: Completed NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT04111471 is a NA study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04111471, a NA study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will look at the effect of the prebiotic inulin compared to placebo on children undergoing stem cell transplant.
Primary Outcome
Compare the effect of oral inulin vs. placebo on alpha and beta bacterial diversity in the stool of children undergoing hematopoietic stem cell transplant
Interventions
- DIETARY_SUPPLEMENT Placebos
- DIETARY_SUPPLEMENT Prebiotics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-10-31 |
| Est. Completion | 2024-11-18 |
| Phase | NA |
What the finished NCT04111471 record still lists
NCT04111471 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebos is the first listed.
NCT04111471 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04111471 about?
NCT04111471 is a clinical study titled "The Use of A Prebiotic to Promote a Healthy Gut Microbiome in Pediatric Stem Cell Transplant Recipients". This study will look at the effect of the prebiotic inulin compared to placebo on children undergoing stem cell transplant.
What is the current status of trial NCT04111471?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2019-10-31. Estimated completion is 2024-11-18.
What interventions are being tested in trial NCT04111471?
The interventions under investigation include: Placebos (DIETARY_SUPPLEMENT), Prebiotics (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04111471?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04111471's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI